Worksheetsdermatology
Total questions: 106
Worksheet time: 53mins
Name
Class
Date
1.
what percent BSA is the head?
a)
0.045
b)
0.09
c)
0.18
2.
what percent BSA is the leg?
a)
0.045
b)
0.09
c)
0.18
3.
what percent BSA is the arm?
a)
0.045
b)
0.09
c)
0.18
4.
what percent BSA is the trunk?
a)
0.045
b)
0.09
c)
0.18
5.
which of the following topical products is the most occlusive?
a)
ointment
b)
creams
c)
lotions
d)
solutions
6.
which of the following topical products is the least occlusive?
a)
ointment
b)
creams
c)
lotions
d)
solutions
7.
which of the following topical products is the most moisturizing?
a)
ointment
b)
creams
c)
lotions
d)
solutions
e)
gel
8.
which of the following topical products is the least moisturizing?
a)
ointment
b)
creams
c)
lotions
d)
solutions
e)
gel
9.
One fingertip unit (FTU) is roughly 0.5 g and treats 2% of BSA
a)
true
b)
false
10.
this type of dermatitis presents as inflammation caused by irritatnts / allergic sensitizers characterized by erythema, vesicles, papules, crusting, or scaling
a)
contact dermatitis
b)
atopic dermatitis
11.
this type of dermatitis presents as chronic, pruritic inflammation, of epidermis/dermis
a)
contact dermatitis
b)
atopic dermatitis
12.
what is the first line treatment for contact dermatitis?
a)
topical corticosteroid
b)
topical Calcineurin inhibitor
c)
topical PDE4 inhibitor
d)
biologics
e)
antihistamines
13.
what is the first line treatment for atopic dermatitis?
a)
topical corticosteroid
b)
topical Calcineurin inhibitor
c)
topical PDE4 inhibitor
d)
biologics
e)
antihistamines
14.
which topical corticosteroid is low potency?
a)
desonide
b)
hydrocortisone
c)
betamethasone dipropionate
d)
triamcinolone
e)
fluticasone
15.
which topical corticosteroid is medium potency?
a)
betamethasone valerate
b)
betamethasone dipropionate
c)
triamcinolone
d)
flurandrenolide
e)
fluticasone
16.
which topical corticosteroid is high potency?
a)
fluocinonide
b)
desoximetasone
c)
halobetasol
d)
betamethasone valerate
e)
betamethasone dipropionate
17.
which topical corticosteroid is high potency?
a)
clobetasol
b)
fluocinonide
c)
desoximetasone
d)
halobetasol
18.
which type of dermatitis is often described as "the itch that rashes, rather than the rash that itches?"
a)
atopic
b)
contact
19.
which of the following is second line treatment for atopic dermatitis?
a)
topical corticosteroid
b)
topical Calcineurin inhibitor
c)
topical PDE4 inhibitor
d)
biologics
e)
antihistamines
20.
tacrolimus is what class of medication used to treat atopic dermtitis?
a)
topical corticosteroid
b)
topical Calcineurin inhibitor
c)
topical PDE4 inhibitor
d)
biologics
e)
antihistamines
21.
pimecrolimus is what class of medication used to treat atopic dermtitis?
a)
topical corticosteroid
b)
topical Calcineurin inhibitor
c)
topical PDE4 inhibitor
d)
biologics
e)
antihistamines
22.
which TCI is used for moderate to severe atopic dermatitis?
a)
tacrolimus
b)
pimecrolimus
23.
which TCI is used for mild to moderate atopic dermatitis?
a)
tacrolimus
b)
pimecrolimus
24.
which clss of medication used to treat atopic dermatitis has a boxed warning of malignancy?
a)
topical corticosteroid
b)
topical Calcineurin inhibitor
c)
topical PDE4 inhibitor
d)
biologics
e)
antihistamines
25.
which type of topical corticosteroid is appropriate for thin skin / high penetration areas (face, groin, axillae)
a)
low potency
b)
medium potency
c)
high potency
26.
which type of topical corticosteroid is appropriate for poor penetration areas (elbow, knees, soles)
a)
low potency
b)
medium potency
c)
high potency
27.
which type of topical corticosteroid is appropriate for the body
a)
low potency
b)
medium potency
c)
high potency
28.
immunocompromised adults with atopic dermatitis is CONTRAINDICATED for use with which type of medication?
a)
topical corticosteroid
b)
topical Calcineurin inhibitor
c)
topical PDE4 inhibitor
d)
biologics
e)
antihistamines
29.
which medication class carries the risk of cutaneous atrophy?
a)
topical corticosteroid
b)
topical Calcineurin inhibitor
c)
topical PDE4 inhibitor
d)
biologics
e)
antihistamines
30.
crisaborole (eucrisa) is what class of medication used to treat atopic dermatitis?
a)
topical corticosteroid
b)
topical Calcineurin inhibitor
c)
topical PDE4 inhibitor
d)
biologics
e)
antihistamines
31.
crisaborole (eucris) is approved for what severity of atopic dermatitis?
a)
mild to moderate
b)
moderate to severe
32.
match the description to the severity of acne: comedones +/- few pustules or papules
a)
mild
b)
moderate
c)
severe
d)
very severe
33.
match the description to the severity of acne: comedones, severeal pustules or papules, +/- few nodules
a)
mild
b)
moderate
c)
severe
d)
very severe
34.
match the description to the severity of acne: numerous pustules or papules and many nodules (may include perisisent nodules, extensive scarring, drainage, or formtion of sinus tracts)
a)
mild
b)
moderate
c)
severe
d)
very severe
35.
match the description to the severity of acne: acne variants (eg. acne conglobata)
a)
mild
b)
moderate
c)
severe
d)
very severe
36.
which of the following pharmacologic treatments is reccomended for mild acne?
a)
isotretinoin
b)
spironolactone
c)
Benzoyl Peroxide (BP)
d)
Topical Retinoid
e)
Topical Combinations
37.
which of the following pharmacologic treatments is reccomended for moderate acne?
a)
isotretinoin
b)
spironolactone
c)
Benzoyl Peroxide (BP)
d)
Topical Retinoid
e)
Topical Combinations
38.
which of the following pharmacologic treatments is a second line treatment for moderate acne?
a)
isotretinoin
b)
spironolactone
c)
combined oral contraceptive
d)
Topical Retinoid
e)
Topical Combinations
39.
which of the following pharmacologic treatments is reccomended for moderate acne?
a)
isotretinoin
b)
BP + retinoid + topical and oral antibiotics
c)
BP + retinoid
d)
BP + retinoid + oral antibiotic
e)
Topical Combinations
40.
which of the following pharmacologic treatments is reccomended for severe acne?
a)
isotretinoin
b)
spironolactone
c)
BP + retinoid
d)
BP + retinoid + oral antibiotic
e)
Topical Combination + oral antibiotic
41.
which of the following pharmacologic treatments is a second line treatment for severe acne?
a)
isotretinoin
b)
spironolactone
c)
combined oral contraceptive
d)
Topical Retinoid
e)
Topical Combinations
42.
which medication is the standard of care for mild to moderate popular pustular acne?
a)
benzoyl peroxide
b)
dapsone
c)
retinol
d)
antibiotics
43.
which medication may take 2-3 months to see improvement?
a)
benzoyl peroxide
b)
dapsone
c)
retinol
d)
antibiotics
44.
which of the following retinoids is pregnancy category X?
a)
tretinoin
b)
adapalene
c)
tazarotene
45.
which of the following retinoids is the least tolerated topical retinoid?
a)
tretinoin
b)
adapalene
c)
tazarotene
46.
which of the following retinoids is the least irritating / first choice topical retinoid?
a)
tretinoin
b)
adapalene
c)
tazarotene
47.
which of the following retinoids is non-specific affinity for retinoic acid receptors?
a)
tretinoin
b)
adapalene
c)
tazarotene
48.
which medication will you start to see efficacy stating within 4 weeks, with full effects taking 2-3 months?
a)
benzoyl peroxide
b)
dapsone
c)
retinol
d)
topical antibiotics
49.
which medication is reserved for moderate to severe acne?
a)
benzoyl peroxide
b)
dapsone
c)
retinol
d)
topical antibiotics
e)
oral antibiotics
50.
which of the antibiotic use is not recommended for acne because of the lack of evidence?
a)
doxycycline
b)
azithromycin
c)
bactrim
d)
minocycline
51.
what is the first line therapy for psoriasis?
a)
topical corticosteroid
b)
retinoids
c)
vitamin D analogues
d)
topical calcinurin inhibitors
e)
anthralin
52.
what is the second line therapy for psoriasis?
a)
topical corticosteroid
b)
retinoids
c)
vitamin D analogues
d)
topical calcinurin inhibitors
e)
anthralin
53.
what is the second line therapy for psoriasis?
a)
topical corticosteroid
b)
retinoids
c)
salicyclic acid
d)
coal tar
e)
anthralin
54.
for mild to moderate psoriasis, which of the following would be an appropriate theapy if the patient has not tried anything yet?
a)
topical agents
b)
topical agents + phototherapy
c)
topical agents + systemic agent
d)
systemic agent +/- topical agent / phototherapy
e)
biologic agent
55.
for mild to moderate psoriasis, which of the following would be an appropriate theapy if the patient has tried topical agents and treatment was inadequate / ineffective?
a)
topical agents
b)
topical agents + phototherapy
c)
topical agents + systemic agent
d)
systemic agent +/- topical agent / phototherapy
e)
biologic agent
56.
for mild to moderate psoriasis, which of the following would be an appropriate theapy if the patient has tried topical agents + phototherapy and the treatment was inadequate / ineffective?
a)
topical agents
b)
topical agents + phototherapy
c)
topical agents + systemic agent
d)
systemic agent +/- topical agent / phototherapy
e)
biologic agent
57.
for moderate to severe psoriasis, which of the following would be an appropriate therapy if the patient has not tried anything yet?
a)
topical agents
b)
topical agents + phototherapy
c)
topical agents + systemic agent
d)
systemic agent +/- topical agent / phototherapy
e)
biologic agent
58.
which of the following is first line systemic agents?
a)
methotrexate
b)
cyclosoprine
c)
azathioprine
d)
leflunomide
59.
which of the following is first line systemic agents?
a)
retinoids
b)
otezla
c)
mycophenolate
d)
sulfasalazine
60.
for the treatment of psoriasis in pregnant ladies, which of the following medication is the treatment of choice?
a)
topical corticosteroid
b)
topical retinoids
c)
topical calcineurin inhibitors
d)
systemic agents
61.
which of the following medications is not recommended if patient's psoriasis is >20% BSA?
a)
topical corticosteroid
b)
topical retinoids
c)
topical calcineurin inhibitors
d)
systemic agents
62.
which of the following medication is teratogenic / pregnancy category X?
a)
oral retinoid
b)
TNF-alpha inhibitors
c)
oral PDE-4 inhibitor
d)
interleukin inhibitor
63.
which of the following medication is teratogenic / pregnancy category X?
a)
acitretin
b)
adalimumab
c)
otezla
d)
cyclosporin
64.
penicillins, cephalosporins, sulfonamides, anticonvulsants most commonly trigger what type of skin reaction?
a)
exanthematous
b)
urticaria
c)
angioedema
d)
SJS
e)
TENS
65.
penicillins, sulfonamides, ASA, opioids most commonly trigger what type of skin reaction?
a)
exanthematous
b)
urticaria
c)
angioedema
d)
SJS
e)
TENS
66.
ACEi, ARBs, NSAIDs most commonly trigger what type of skin reaction?
a)
exanthematous
b)
urticaria
c)
angioedema
d)
SJS
e)
TENS
67.
sulfonamides, allopurinol, carbamazepine, fluoroquinolone most commonly trigger what type of skin reaction?
a)
exanthematous
b)
urticaria
c)
angioedema
d)
SJS
e)
TENS
68.
aminopenicillins, sulfonamides, allopurinol, carbamazepine most commonly trigger what type of skin reaction?
a)
exanthematous
b)
urticaria
c)
angioedema
d)
SJS
e)
TENS
69.
amiodarone, thiazides, NSAIDs, fluoroquinolones, retinoids most commonly trigger what type of skin reaction?
a)
photosensitivity
b)
hyperpigmentation
c)
red man
d)
purple toe
e)
warfarin necrosis
70.
amiodarone, oral contraceptoves, carbamazepine most commonly trigger what type of skin reaction?
a)
photosensitivity
b)
hyperpigmentation
c)
red man
d)
purple toe
e)
warfarin necrosis
71.
vancomycin most commonly trigger what type of skin reaction?
a)
photosensitivity
b)
hyperpigmentation
c)
red man
d)
purple toe
e)
warfarin necrosis
72.
heparin / warfarin most commonly trigger what type of skin reaction?
a)
photosensitivity
b)
hyperpigmentation
c)
red man
d)
purple toe
e)
warfarin necrosis
73.
warfarin most commonly trigger what type of skin reaction?
a)
photosensitivity
b)
hyperpigmentation
c)
red man
d)
purple toe
e)
warfarin necrosis
74.
chemoterapeutics, interferons most comonly cause what type of skin reaction?
a)
alopecia
b)
hirsutism
c)
exanthematous
d)
urticaria
e)
angioedema
75.
testosterone, glucocorticoids, anabolic steroids most commonly cause what type of skin reaction?
a)
alopecia
b)
hirsutism
c)
exanthematous
d)
urticaria
e)
angioedema
76.
which of the following formulations would be ideal to use for weeping / oozing / vesication conditions?
a)
ointment
b)
creams
c)
lotions
d)
solutions
e)
gel
77.
which of the following is NOT a characteristic of dermatitis / eczema?
a)
macules
b)
papules
c)
vesicles
d)
crusting
e)
scaling
78.
which of the following is NOT a characteristic of dermatitis / eczema?
a)
macules
b)
patches
c)
plaques
d)
extremly pruitic
e)
erythema
79.
macules are dermatologic lesions that:
a)
nonpalpable, flat, change in color, <1 cm
b)
paplpable, soid mass, nay have change in color, <1cm
c)
palpable, solid mass, most often below the plane of the skin, 1-2cm
d)
superficial area of cutaneous edema, fluid not confied to cavity
e)
palpable, fluid filled cavity, <1cm, filled with serous fluid
80.
papule are dermatologic lesions that:
a)
nonpalpable, flat, change in color, <1 cm
b)
paplpable, soid mass, nay have change in color, <1cm
c)
palpable, solid mass, most often below the plane of the skin, 1-2cm
d)
superficial area of cutaneous edema, fluid not confied to cavity
e)
palpable, fluid filled cavity, <1cm, filled with serous fluid
81.
nodule are dermatologic lesions that:
a)
nonpalpable, flat, change in color, <1 cm
b)
paplpable, soid mass, nay have change in color, <1cm
c)
palpable, solid mass, most often below the plane of the skin, 1-2cm
d)
superficial area of cutaneous edema, fluid not confied to cavity
e)
palpable, fluid filled cavity, <1cm, filled with serous fluid
82.
wheal are dermatologic lesions that:
a)
nonpalpable, flat, change in color, <1 cm
b)
paplpable, soid mass, nay have change in color, <1cm
c)
palpable, solid mass, most often below the plane of the skin, 1-2cm
d)
superficial area of cutaneous edema, fluid not confied to cavity
e)
palpable, fluid filled cavity, <1cm, filled with serous fluid
83.
vesicle are dermatologic lesions that:
a)
nonpalpable, flat, change in color, <1 cm
b)
paplpable, soid mass, nay have change in color, <1cm
c)
palpable, solid mass, most often below the plane of the skin, 1-2cm
d)
superficial area of cutaneous edema, fluid not confied to cavity
e)
palpable, fluid filled cavity, <1cm, filled with serous fluid
84.
pustule are dermatologic lesions that:
a)
palpable, fluid filled cavity, <1cm, filled with purulent fluid
b)
thickening of epidermis, usually induced by scratching or chronic inflammation
c)
palpable, solid mass, most often below the plane of the skin, 1-2cm
d)
superficial area of cutaneous edema, fluid not confied to cavity
e)
palpable, fluid filled cavity, <1cm, filled with serous fluid
85.
lichenification are dermatologic lesions that:
a)
palpable, fluid filled cavity, <1cm, filled with purulent fluid
b)
thickening of epidermis, usually induced by scratching or chronic inflammation
c)
palpable, solid mass, most often below the plane of the skin, 1-2cm
d)
superficial area of cutaneous edema, fluid not confied to cavity
e)
palpable, fluid filled cavity, <1cm, filled with serous fluid
86.
which of the following is NOT a characteristic of contact dermatitis?
a)
macules
b)
papules
c)
vesicles
d)
crusting
e)
scaling
87.
which of the following is NOT a characteristic of contact dermatitis?
a)
macules
b)
papules
c)
plaques
d)
extremly pruitic
e)
erythema
88.
irritant contact dermatitis lesions:
a)
remain localized to area of contact
b)
extend to more than just area of contact but rarely become systemic
89.
allergic contact dermatitis lesions:
a)
remain localized to area of contact
b)
extend to more than just area of contact but rarely become systemic
90.
which of the following is NOT a characteristic of atopic dermatitis?
a)
pruritis
b)
periods of exacerbations / flares and remissions
c)
xerosis (dry skin)
d)
crusting
e)
papules
91.
topical retinoids may take:
a)
2-3 months to see improvement
b)
efficacy starts within 4 weeks, with full effects within 2-3 months
c)
3-4 months, must reevaluate therapy after
92.
topical antibiotics may take:
a)
2-3 months to see improvement
b)
efficacy starts within 4 weeks, with full effects within 2-3 months
c)
3-4 months, must reevaluate therapy after
93.
oral antibiotics may take:
a)
2-3 months to see improvement
b)
efficacy starts within 4 weeks, with full effects within 2-3 months
c)
3-4 months, must reevaluate therapy after
94.
benzoyl peroxides MOA is:
a)
eradication of P.acnes, suppresses sebum production, comedolytic and anti-inflammatory
b)
reduces obstruction within the follicle and inhibit microcomedone formation
c)
sulfone with antibacterial and anti-inflammatory effects
d)
reduces P.acnes colonization and inhibits bacterial pro-inflammatory mediators
e)
improves follicular epithelial differentiation, reduces inflammation, P.acnes growth, and sebaceous gland activity
95.
topical retinoids MOA is:
a)
eradication of P.acnes, suppresses sebum production, comedolytic and anti-inflammatory
b)
reduces obstruction within the follicle and inhibit microcomedone formation
c)
sulfone with antibacterial and anti-inflammatory effects
d)
reduces P.acnes colonization and inhibits bacterial pro-inflammatory mediators
e)
improves follicular epithelial differentiation, reduces inflammation, P.acnes growth, and sebaceous gland activity
96.
dapsone's MOA is:
a)
eradication of P.acnes, suppresses sebum production, comedolytic and anti-inflammatory
b)
reduces obstruction within the follicle and inhibit microcomedone formation
c)
sulfone with antibacterial and anti-inflammatory effects
d)
reduces P.acnes colonization and inhibits bacterial pro-inflammatory mediators
e)
improves follicular epithelial differentiation, reduces inflammation, P.acnes growth, and sebaceous gland activity
97.
topical antibiotics MOA is:
a)
eradication of P.acnes, suppresses sebum production, comedolytic and anti-inflammatory
b)
reduces obstruction within the follicle and inhibit microcomedone formation
c)
sulfone with antibacterial and anti-inflammatory effects
d)
reduces P.acnes colonization and inhibits bacterial pro-inflammatory mediators
e)
improves follicular epithelial differentiation, reduces inflammation, P.acnes growth, and sebaceous gland activity
98.
oral retinoid / isotretinoin MOA is:
a)
eradication of P.acnes, suppresses sebum production, comedolytic and anti-inflammatory
b)
reduces obstruction within the follicle and inhibit microcomedone formation
c)
sulfone with antibacterial and anti-inflammatory effects
d)
reduces P.acnes colonization and inhibits bacterial pro-inflammatory mediators
e)
improves follicular epithelial differentiation, reduces inflammation, P.acnes growth, and sebaceous gland activity
99.
which of the following medications for acne may have prolong remission rates?
a)
dapsone
b)
adapelene
c)
doxycycline
d)
clindamycin
e)
isotretinoin
100.
which topical retinoids is the least irritating retinoid and may be helpful in patients with sensitive skin?
a)
tretinoin
b)
adapelene
c)
tazorotene
d)
isotretinoin
101.
which topical retinoids is oxidized and inactivated by coadministration with benzoyl peroxide? Recommend these agents to be applied at different times
a)
tretinoin
b)
adapelene
c)
tazorotene
d)
isotretinoin
102.
which topical retinoid has non specific affinity for retinoic acid receptors?
a)
tretinoin
b)
adapelene
c)
tazorotene
d)
isotretinoin
103.
which topical retinoid has specific affinity for retinoic acid receptors?
a)
tretinoin
b)
adapelene
c)
tazorotene
d)
isotretinoin
104.
which topical retinoid is the least tolerated topical retinoid and not degraded by sunlight>
a)
tretinoin
b)
adapelene
c)
tazorotene
d)
isotretinoin
105.
which of the following medications is not recommended if patient's psoriasis is >20% BSA?
a)
tazarotene
b)
betamethasone
c)
calcipotriene
d)
pimecrolimus
106.
which of the following topical retinoids is approved for the treatment of mild to moderate psoriasis?
a)
tretinoin
b)
adapelene
c)
tazorotene
d)
isotretinoin
100 %
